Microbot Medical Inc. Daily Stock Analysis

Daily Stock Analysis, MBOT, Microbot Medical Inc, priceseries

Microbot Medical Inc. Daily Stock Analysis
Stock Information
Open
5.41
Close
5.11
High
5.45
Low
4.90
Previous Close
5.46
Daily Price Gain
-0.35
YTD High
7.91
YTD High Date
Jan 3, 2022
YTD Low
4.70
YTD Low Date
Feb 24, 2022
YTD Price Change
-2.62
YTD Gain
-33.89%
52 Week High
9.75
52 Week High Date
Mar 15, 2021
52 Week Low
4.31
52 Week Low Date
Dec 15, 2021
52 Week Price Change
-2.74
52 Week Gain
-34.90%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 17. 2017
75.75
Mar 8. 2017
92.99
12 Trading Days
22.76%
Link
LONG
May 31. 2017
67.80
Jun 2. 2017
72.60
2 Trading Days
7.08%
Link
LONG
Jan 7. 2019
1.89
Jan 30. 2019
8.40
16 Trading Days
344.26%
Link
LONG
Dec 4. 2019
4.95
Dec 17. 2019
5.70
9 Trading Days
15.10%
Link
LONG
Dec 23. 2019
10.11
Dec 27. 2019
11.08
3 Trading Days
9.62%
Link
LONG
Jan 10. 2020
13.17
Jan 13. 2020
14.46
1 Trading Days
9.79%
Link
LONG
Apr 23. 2020
6.22
May 1. 2020
6.73
6 Trading Days
8.14%
Link
LONG
Dec 22. 2021
5.06
Jan 5. 2022
6.90
9 Trading Days
36.31%
Link
Company Information
Stock Symbol
MBOT
Exchange
NasdaqCM
Company URL
http://www.microbotmedical.com
Company Phone
908-938-5561
CEO
Harel Gadot
Headquarters
Massachusetts
Business Address
175 DERBY ST. 27/1, ., HINGHAM, MA 02043
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0000883975
About

Microbot Medical, Inc. engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. Its carries out its operations through the ViRob and TipCat paltforms. The company's ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt (SCS), a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid (CSF) shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCAT platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. It is developed for use in colonoscopy procedures. The company was founded by Harel Gadot, Moshe Shoham, and Yossi Bornstein in 2010, and is headquartered in Hingham, MA.

Description

Microbot Medical Inc., a medical device company, engages in the research, design, development, and commercialization of micro-robotics medical technologies. Its ViRob and TipCAT platforms consist of micro-robotic technologies, from which the company is developing its product candidates, including the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH); and a self-propelling, semi-disposable endoscope that is being developed initially for use in colonoscopy procedures. The company was founded in 2010 and is based in Yokneam, Israel.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading